122 related articles for article (PubMed ID: 31063493)
21. Prolactin-induced activation of STAT5 within the hypothalamic arcuate nucleus.
Cave BJ; Norman M; Flynn A; Townsend J; Wakerley JB; Tortonese DJ
Neuroreport; 2005 Sep; 16(13):1423-6. PubMed ID: 16110263
[TBL] [Abstract][Full Text] [Related]
22. Serotonin suppresses β-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A.
Chiba T; Kimura S; Takahashi K; Morimoto Y; Sanbe A; Ueda H; Kudo K
Biol Pharm Bull; 2014; 37(8):1336-40. PubMed ID: 25087955
[TBL] [Abstract][Full Text] [Related]
23. Prolactin induces phosphorylation of the STAT5 in adrenal glands of Hatano rats during stress.
Jaroenporn S; Nagaoka K; Ohta R; Watanabe G; Taya K
Life Sci; 2009 Jul; 85(3-4):172-7. PubMed ID: 19481553
[TBL] [Abstract][Full Text] [Related]
24. Lack of cross-desensitization between leptin and prolactin signaling pathways despite the induction of suppressor of cytokine signaling 3 and PTP-1B.
Roy AF; Benomar Y; Bailleux V; Vacher CM; Aubourg A; Gertler A; Djiane J; Taouis M
J Endocrinol; 2007 Nov; 195(2):341-50. PubMed ID: 17951545
[TBL] [Abstract][Full Text] [Related]
25. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
Russell DL; Richards JS
Mol Endocrinol; 1999 Dec; 13(12):2049-64. PubMed ID: 10598581
[TBL] [Abstract][Full Text] [Related]
26. A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: the complex is not the prolactin receptor.
Lorenson MY; Ueda EK; Chen KE; Walker AM
Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E585-94. PubMed ID: 22205628
[TBL] [Abstract][Full Text] [Related]
27. A novel design of targeted endocrine and cytokine therapy for breast cancer.
Zhang G; Li W; Holle L; Chen N; Chen WY
Clin Cancer Res; 2002 Apr; 8(4):1196-205. PubMed ID: 11948133
[TBL] [Abstract][Full Text] [Related]
28. Bovine prolactin elevates hTF expression directed by a tissue-specific goat β-casein promoter through prolactin receptor-mediated STAT5a activation.
Jiang S; Ren Z; Xie F; Yan J; Huang S; Zeng Y
Biotechnol Lett; 2012 Nov; 34(11):1991-9. PubMed ID: 22829284
[TBL] [Abstract][Full Text] [Related]
29. CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy.
Mapes J; Li Q; Kannan A; Anandan L; Laws M; Lydon JP; Bagchi IC; Bagchi MK
PLoS Genet; 2017 Mar; 13(3):e1006654. PubMed ID: 28278176
[TBL] [Abstract][Full Text] [Related]
30. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
Jabbour HN; Critchley HO; Boddy SC
J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
[TBL] [Abstract][Full Text] [Related]
31. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
[TBL] [Abstract][Full Text] [Related]
32. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.
Llovera M; Pichard C; Bernichtein S; Jeay S; Touraine P; Kelly PA; Goffin V
Oncogene; 2000 Sep; 19(41):4695-705. PubMed ID: 11032019
[TBL] [Abstract][Full Text] [Related]
33. A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.
Wakao H; Chida D; Damen JE; Krystal G; Miyajima A
Biochem Biophys Res Commun; 1997 May; 234(1):198-205. PubMed ID: 9168989
[TBL] [Abstract][Full Text] [Related]
34. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context.
Gutzman JH; Rugowski DE; Nikolai SE; Schuler LA
Oncogene; 2007 Sep; 26(43):6341-8. PubMed ID: 17438530
[TBL] [Abstract][Full Text] [Related]
35. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
Carsol JL; Gingras S; Simard J
Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
37. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
38. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the rat liver sodium-dependent bile acid cotransporter gene by prolactin. Mediation of transcriptional activation by Stat5.
Ganguly TC; O'Brien ML; Karpen SJ; Hyde JF; Suchy FJ; Vore M
J Clin Invest; 1997 Jun; 99(12):2906-14. PubMed ID: 9185514
[TBL] [Abstract][Full Text] [Related]
40. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
Goffin V
Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
